Hepatitis C infection in patients with chronic kidney disease

被引：7
作者：
Mangia, A. [2 ]
Burra, P. [3 ]
Ciancio, A. [4 ]
Fagiuoli, S. [5 ]
Guido, M. [6 ]
Picciotto, A. [7 ]
Fabrizi, F. [1 ]
机构：
[1] Maggiore Hosp, IRCCS, Div Nephrol, I-20122 Milan, Italy
[2] IRCCS, Gen Hosp, Div Gastroenterol, San Giovanni Rotondo, Italy
[3] Univ Padua, Div Gastroenterol, Padua, Italy
[4] AO San Giovanni Battista, Div Gastroenterol, Turin, Italy
[5] Osped Riuniti Bergamo, Div Gastroenterol, I-24100 Bergamo, Italy
[6] Univ Padua, Dept Pathol, I-35100 Padua, Italy
[7] Univ Genoa, Dept Internal Med, I-16126 Genoa, Italy
来源：
INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS | 2008年 / 31卷 / 01期
关键词：
hepatitis C; chronic kidney disease; dialysis; renal transplantation;
D O I：
10.1177/039139880803100104
中图分类号：
R318 [生物医学工程];
学科分类号：
0831 ;
摘要：
The management of hepatitis C virus (HCV)-infected patients with chronic kidney disease (CKD) is complex and represents a particular concern since numerous issues, such as antiviral therapy in dialysis patients and post renal transplant, and prevention of HCV spread within dialysis units, remain unresolved. An enormous body of literature has been published on HCV in the CKD population; however, clinical evidence on important issues is mostly based on uncontrolled clinical trials or retrospective surveys. The aim of this paper is to provide a systematic review of the literature. Responses to the critical issues have been developed by a consensus of experts, endorsed by the Italian Association for the Study of the Liver (AISF) and some clinical recommendations have been added.
引用
收藏
页码：15 / 33
页数：19
相关论文
共 148 条
[31]   Hepatitis C virus infection and de novo glomerular lesions in renal allografts [J].
Cruzado, JM ;
Carrera, M ;
Torras, J ;
Grinyó, JM .
AMERICAN JOURNAL OF TRANSPLANTATION, 2001, 1 (02) :171-178
[32]   Pretransplant interferon prevents hepatitis C virus-associated glomerulonephritis in renal allografts by HCV-RNA clearance [J].
Cruzado, JM ;
Casanovas-Taltavull, T ;
Torras, J ;
Baliellas, C ;
Gil-Vernet, S ;
Grinyó, JM .
AMERICAN JOURNAL OF TRANSPLANTATION, 2003, 3 (03) :357-360
[33]   The tolerance and efficacy of interferon-α in haemodialysis patients with HCV infection:: a multicentre, prospective study [J].
Degos, F ;
Pol, S ;
Chaix, ML ;
Laffitte, V ;
Buffet, C ;
Bernard, PH ;
Degott, C ;
Carnot, F ;
Riffaud, PC ;
Chevret, S .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2001, 16 (05) :1017-1023
[34]   The course of hepatitis C virus infection in pretransplantation anti-hepatitis C virus-negative renal transplant recipients: A retrospective follow-up study [J].
Delladetsima, I ;
Psichogiou, M ;
Sypsa, V ;
Psimenou, E ;
Kostakis, A ;
Hatzakis, A ;
Boletis, JN .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2006, 47 (02) :309-316
[35]   Epidemiology of hepatitis C virus among long-term dialysis patients: A 9-year study in an Italian region [J].
Di Napoli, Anteo ;
Pezzotti, Patrizio ;
Di Lallo, Domenico ;
Petrosillo, Nicola ;
Trivelloni, Claudia ;
Di Giulio, Salvatore .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2006, 48 (04) :629-637
[36]  
Espinosa M, 2007, CLIN NEPHROL, V67, P366
[37]  
Espinosa M, 2000, CLIN NEPHROL, V54, P151
[38]  
Espinosa M, 2002, CLIN NEPHROL, V58, P143
[39]   Risk of death and liver cirrhosis in anti-HCV-positive long-term haemodialysis patients [J].
Espinosa, M ;
Martin-Malo, A ;
de Lara, MAA ;
Ajama, P .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2001, 16 (08) :1669-1674
[40]   Meta-analysis: anti-viral therapy of hepatitis C virus-related liver disease in renal transplant patients [J].
Fabrizi, F. ;
Lunghi, G. ;
Dixit, V. ;
Martin, P. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2006, 24 (10) :1413-1422
12345678910